Management of gastric varices: still a matter of debate?

Affiliations

¹ Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, IDIBAPS, CIBER, Hospital Clinic de Barcelona 08036, Spain; Iuliu Hatieganu University of Medicine and Pharmacy, IRGH, Cluj-Napoca, Romania.
² Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, IDIBAPS, CIBER, Hospital Clinic de Barcelona 08036, Spain. Electronic address: abaigesa@clinic.cat.

Comment

Oana Nicoara-Farcau et al. Lancet Gastroenterol Hepatol. 2022 Aug.

. 2022 Aug;7(8):693-694.

doi: 10.1016/S2468-1253(22)00157-1. Epub 2022 May 17.

¹ Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, IDIBAPS, CIBER, Hospital Clinic de Barcelona 08036, Spain; Iuliu Hatieganu University of Medicine and Pharmacy, IRGH, Cluj-Napoca, Romania.
² Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, IDIBAPS, CIBER, Hospital Clinic de Barcelona 08036, Spain. Electronic address: abaigesa@clinic.cat.

No abstract available

Conflict of interest statement

We declare no competing interests.

Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial.
Lv Y, Chen H, Luo B, Bai W, Li K, Wang Z, Xia D, Guo W, Wang Q, Li X, Yuan J, Cai H, Xia J, Yin Z, Fan D, Han G. Lv Y, et al. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):736-746. doi: 10.1016/S2468-1253(22)00087-5. Epub 2022 May 17. Lancet Gastroenterol Hepatol. 2022. PMID: 35588750 Clinical Trial.